Invention Grant
![Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors](/docs/US/2011-11-08/US08053433B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
-
Application No.: US11980314Application Date: 2007-10-30
-
Publication No.: US08053433B2Publication Date: 2011-11-08
- Inventor: James D. Rodgers , Haisheng Wang , Andrew P. Combs , Richard B. Sparks
- Applicant: James D. Rodgers , Haisheng Wang , Andrew P. Combs , Richard B. Sparks
- Applicant Address: US DE Wilmington
- Assignee: Ineyte Corporation
- Current Assignee: Ineyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/535
- IPC: A61K31/535 ; A61K31/44
![Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors](/abs-image/US/2011/11/08/US08053433B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides pyrrolo[2,3-b]pyridine-4-yl amines pyrrolo[2,3-b]pyrimidin-4-yl amines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases and cancer.
Public/Granted literature
- US20110086835A1 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors Public/Granted day:2011-04-14
Information query
